Next Biometrics Group Stock Cash And Equivalents
| NEXT Stock | NOK 6.50 0.42 6.07% |
Next Biometrics Group fundamentals help investors to digest information that contributes to Next Biometrics' financial success or failures. It also enables traders to predict the movement of Next Stock. The fundamental analysis module provides a way to measure Next Biometrics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Next Biometrics stock.
Next |
Next Biometrics Group Company Cash And Equivalents Analysis
Next Biometrics' Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current Next Biometrics Cash And Equivalents | 102.71 M |
Most of Next Biometrics' fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Next Biometrics Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
| Competition |
In accordance with the recently published financial statements, Next Biometrics Group has 102.71 M in Cash And Equivalents. This is 91.78% lower than that of the Electronic Equipment, Instruments & Components sector and 57.96% lower than that of the Information Technology industry. The cash and equivalents for all Norway stocks is 96.2% higher than that of the company.
Next Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Next Biometrics' direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Next Biometrics could also be used in its relative valuation, which is a method of valuing Next Biometrics by comparing valuation metrics of similar companies.Next Biometrics is currently under evaluation in cash and equivalents category among its peers.
Next Fundamentals
| Return On Equity | -0.41 | |||
| Return On Asset | -0.21 | |||
| Profit Margin | (1.09) % | |||
| Operating Margin | (1.09) % | |||
| Current Valuation | 323.14 M | |||
| Shares Outstanding | 91.98 M | |||
| Shares Owned By Insiders | 50.79 % | |||
| Shares Owned By Institutions | 0.98 % | |||
| Price To Earning | (4.24) X | |||
| Price To Book | 3.48 X | |||
| Price To Sales | 8.51 X | |||
| Revenue | 50.76 M | |||
| Gross Profit | 8.97 M | |||
| EBITDA | (50.98 M) | |||
| Net Income | (58.39 M) | |||
| Cash And Equivalents | 102.71 M | |||
| Cash Per Share | 4.40 X | |||
| Debt To Equity | 4.20 % | |||
| Current Ratio | 7.36 X | |||
| Book Value Per Share | 1.21 X | |||
| Cash Flow From Operations | (47.68 M) | |||
| Earnings Per Share | (0.63) X | |||
| Target Price | 85.0 | |||
| Number Of Employees | 26 | |||
| Beta | 1.31 | |||
| Market Capitalization | 371.14 M | |||
| Total Asset | 161.66 M | |||
| Retained Earnings | (289 M) | |||
| Working Capital | 101 M | |||
| Current Asset | 121 M | |||
| Current Liabilities | 20 M | |||
| Z Score | -1.4 | |||
| Net Asset | 161.66 M |
About Next Biometrics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Next Biometrics Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Next Biometrics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Next Biometrics Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Next Stock
Next Biometrics financial ratios help investors to determine whether Next Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Next with respect to the benefits of owning Next Biometrics security.